Quidel Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Quidel Corp (QDEL) Tops Q1 EPS by 24c, Revenues Beat
May 6, 2020 5:57 PM EDTQuidel Corp (NASDAQ: QDEL) reported Q1 EPS of $1.22, $0.24 better than the analyst estimate of $0.98. Revenue for the quarter came in at $174.7 million versus the consensus estimate of $158.08 million.
First Quarter 2020 Highlights
Total revenue increased 18% to $174.7 million, from $148.0 million in the first quarter of 2019.Cardiometabolic Immunoassay revenue decreased 18% to $53.9 million, and decreased 17% on a constant currency basis.Molecular Diagnostic Solutions revenue grew 45% from the first quarter of 2019 to $8.4 million.Influenza revenue... More